These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 797647)
41. Involvement of vasopressin in corticotropin-releasing effect of hypothalamic median eminence extract. Lutz-Bucher B; Koch B; Mialhe C; Briaud B Neuroendocrinology; 1980; 30(3):178-82. PubMed ID: 6245385 [TBL] [Abstract][Full Text] [Related]
42. Growth hormone expression and secretion in pig pituitary and median eminence slices are not influenced by the VGF protein. Saleri R; Cavalli V; Grasselli F; Tamanini C Neuroendocrinology; 2006; 83(2):89-96. PubMed ID: 16804334 [TBL] [Abstract][Full Text] [Related]
43. Inhibition by gastrin-releasing peptide of growth hormone (GH) secretion induced by human pancreatic GH-releasing factor in rats. Kabayama Y; Kato Y; Shimatsu A; Ohta H; Yanaihara N; Imura H Endocrinology; 1984 Aug; 115(2):649-53. PubMed ID: 6146511 [TBL] [Abstract][Full Text] [Related]
44. Elevation of plasma radioimmunoassayable growth hormone in the rat induced by porcine hypothalamic extract. Malacara JM; Valverde C; Reichlin S; Bollinger J Endocrinology; 1972 Nov; 91(5):1189-98. PubMed ID: 5072800 [No Abstract] [Full Text] [Related]
45. Proceedings: Dose-response characteristics of rat median eminence extract with corticotrophin-releasing activity. Thomas P; Sadow J J Endocrinol; 1975 Mar; 64(3):59P-60P. PubMed ID: 166135 [No Abstract] [Full Text] [Related]
46. Gonadotropic activity of stalk median eminence extracts in hypophysectomized rats. Stevans KR; Jackson GL; Nalbandov AV Endocrinology; 1968 Aug; 83(2):225-33. PubMed ID: 4874283 [No Abstract] [Full Text] [Related]
47. Inhibitory effect of platelet-activating factor (PAF) on luteinizing hormone-releasing hormone and somatostatin release from rat median eminence in vitro correlated with the characterization of specific PAF receptor sites in rat hypothalamus. Junier MP; Tiberghien C; Rougeot C; Fafeur V; Dray F Endocrinology; 1988 Jul; 123(1):72-80. PubMed ID: 2898362 [TBL] [Abstract][Full Text] [Related]
48. A hypothalamic-pituitary system that stimulates the release of plasminogen activator in the rat. Prowse CV; Dow RC; Fink G Brain Res; 1984 May; 299(1):133-8. PubMed ID: 6539143 [TBL] [Abstract][Full Text] [Related]
49. Suppression of human growth hormone (GH)-releasing hormone-induced GH secretion in pentobarbital-anesthetized rats after electrical stimulation of the midbrain central gray and several raphe nuclei. Koibuchi N; Kato M; Kakegawa T; Suzuki M Endocrinology; 1988 Feb; 122(2):659-64. PubMed ID: 3123202 [TBL] [Abstract][Full Text] [Related]
50. Constitutive growth hormone secretion in sheep after hypothalamopituitary disconnection and the direct in vivo pituitary effect of growth hormone releasing peptide 6. Fletcher TP; Thomas GB; Willoughby JO; Clarke IJ Neuroendocrinology; 1994 Jul; 60(1):76-86. PubMed ID: 8090285 [TBL] [Abstract][Full Text] [Related]
51. Vasopressin neurons grafted into Brattleboro rats: viability and activity. Gash D; Sladek JR Peptides; 1980; 1(1):11-4. PubMed ID: 7243606 [TBL] [Abstract][Full Text] [Related]
52. Induction of puberty in immature female rat: effect of estrogen on pituitary FSH and stalk-median-eminence FSH-releasing factor. Corbin A; Daniels EL Neuroendocrinology; 1969; 4(2):65-74. PubMed ID: 4888734 [No Abstract] [Full Text] [Related]
53. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels. Kineman RD; Kamegai J; Frohman LA Endocrinology; 1999 Aug; 140(8):3581-6. PubMed ID: 10433214 [TBL] [Abstract][Full Text] [Related]
54. Failure of stalk-median eminence (SME) extract to suppress serum prolactin levels in rats with hypothalamic islands. Turpen C; Dunn JD Brain Res; 1977 Apr; 125(1):170-4. PubMed ID: 851872 [No Abstract] [Full Text] [Related]
55. Effect of median eminence lesions on [3H]estradiol binding in the anterior pituitary and hypothalamus. Weisenberg LS; De Nicola AF; Arakelian MC; Libertun C Endocrinology; 1979 Nov; 105(5):1152-7. PubMed ID: 488003 [No Abstract] [Full Text] [Related]
56. Estrogen-dependent effects of bombesin on in vivo growth hormone secretion in the rat. Benitez L; Mallo F; Alvarez CV; Burguera B; Sanchez-Franco F; Dieguez C Neuroendocrinology; 1990 Dec; 52(6):608-11. PubMed ID: 1980937 [TBL] [Abstract][Full Text] [Related]
57. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states. Evans WS; Anderson SM; Hull LT; Azimi PP; Bowers CY; Veldhuis JD J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034 [TBL] [Abstract][Full Text] [Related]
58. Pasma growth hormone responses to thyrotropin-releasing hormone in the urethane-anesthetized rat. Kato Y; Chihara K; Maeda K; Ogo S; Okanishi Y Endocrinology; 1975 May; 96(5):1114-8. PubMed ID: 804399 [TBL] [Abstract][Full Text] [Related]
59. Sexual differentiation of growth hormone feedback effects on hypothalamic growth hormone-releasing hormone and somatostatin. Maiter DM; Gabriel SM; Koenig JI; Russell WE; Martin JB Neuroendocrinology; 1990 Feb; 51(2):174-80. PubMed ID: 1968235 [TBL] [Abstract][Full Text] [Related]
60. Hypothalamic hormones. Reichlin S; Saperstein R; Jackson IM; Boyd AE; Patel Y Annu Rev Physiol; 1976; 38():389-424. PubMed ID: 4008 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]